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ABSTRACT 11 
This retrospective case-control study investigates the relationship between seroconversion 12 
to Mycobacterium avium paratuberculosis (MAP) and raised somatic cell count. The study 13 
consists of 112 case cows from 3 dairy farms in the UK, for each case cow with a positive 14 
antibody titre, there was a seronegative control cow for comparison. Seroconversion was 15 
monitored using milk ELISA antibody titres for MAP taken at quarterly intervals. Somatic cell 16 
counts (SCC) were recorded at the time a positive antibody titre was first recorded as well as 17 
at the previous and subsequent milk recording in order to explore a temporal relationship 18 
between the two events. The previous and subsequent milk recordings were a month 19 
before and after seroconversion was identified. 20 
The results showed that cows that were infected with MAP had an increased SCC around 21 
the time that they first became seropositive providing evidence for a temporal relationship 22 
between the two events; high SCC were particularly prevalent before and at the time of first 23 
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detecting seroconversion. The explanation is being discussed that potentially an underlying, 24 
currently not studied, factor may be predisposing both events, the progression of 25 
paratuberculosis is predisposing the host to mastitis, or indeed intramammary infections 26 
help initiate paratuberculosis progression. 27 
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 31 
INTRODUCTION 32 
Paratuberculosis, also known as Johne’s disease, is a chronic, progressive, enteric disease 33 
caused by Mycobacterium avium paratuberculosis (MAP), which primarily affects ruminants. 34 
In addition to the impact of clinical Johne’s disease on cows, there is an interest in the 35 
disease due to the reported association between MAP and the enteric condition Crohn’s 36 
disease in humans1, which has driven efforts to improve disease detection and its 37 
subsequent control. 38 
When the animal is exposed to the pathogen most studies agree that the main portal of 39 
entry is the ileum where the MAP organisms are taken up by M cells within the Peyer’s 40 
patches2,3. MAP organisms can be present in submucosal macrophages 5 hours after 41 
inoculation of a calf’s ileum2, and due to MAP’s ability to survive within macrophages it is 42 
likely that the organisms will persist within these cells4,5. At the early stage of the disease, 43 
the host’s immune defences prevent any outward clinical signs and contain the pathogen 44 
within the intestine and its associated lymphoid tissue through granuloma formation. As the 45 
disease progresses though this granulomatous response becomes more severe and diffuse, 46 
eventually becoming the cause of the clinical signs6. 47 
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An important stage of the infection’s progression is the transition in immune response from 48 
one which is predominantly cell-mediated, stimulated by Th-1 cells and aimed against 49 
intracellular pathogens; to one which is antibody-mediated, stimulated by Th-2 cells and 50 
aimed against extracellular pathogens7. In the early stages of infection there is a strong bias 51 
towards a Th-1 immune mediated response; the cytokine interferon-γ has a crucial role in 52 
this bias8,9,10 and is found in higher amounts from animals infected with MAP along with 53 
other proinflammatory cytokines inducing a strong cell mediated immune response11,12. 54 
With clinical progression, a switch from a mainly cell mediated response to a humoral 55 
immune response occurs12,13,14. This event coincides with an increase in faecal shedding of 56 
MAP, and seroconversion is therefore used to indicate MAP shedding cows in the control of 57 
paratuberculosis7,15,16. 58 
An impaired immune system due to the infection with MAP is hypothesised to be the reason 59 
that these animals are more prone to subclinical mastitis 17,18. Although some studies have 60 
found no significant difference in somatic cell count (SCC) levels in the milk between 61 
paratuberculosis affected and non-affected animals19,20,21,22,23, others reported an increase 62 
in SCC24 as well as an increase in culling rates due to mastitis associated with MAP 63 
infection25. A longitudinal study reported a first high SCC in 46% of the cows before MAP 64 
antibodies were found and reversely 40% of the cows were identified as MAP positive first 65 
26. It is, however, uncertain what the direction is of causality of this association. In order to 66 
gain a level of insight into this, in this study we have looked into the temporal relationship 67 
between MAP infected cattle and subclinical mastitis. This looks specifically at the moment 68 
a first seropositive result is recorded, using this as an indicator for the disease’s transition in 69 
immune response 7,27 and somatic cell count is used as an indicator of intramammary 70 
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infection28. We examine the SCC before, after and at seroconversion to MAP in three UK 71 
dairy herds, in a retrospective longitudinal matched case-control study.  72 
 73 
MATERIALS AND METHODS 74 
Data Sources 75 
The sample population consisted of all milking cows from three Holstein-Friesian dairy farms 76 
in England. The farms were selected based on their long-term testing for paratuberculosis 77 
and were taking part in the Herdwise Johne’s Screening Programme (National Milk 78 
Laboratories, Chippenham, UK). Milk samples were taken on a monthly basis for National 79 
Milk Records to measure SCC. These milk samples were additionally tested every three 80 
months for antibodies against MAP using an ELISA. Antibody titres, SCC levels cow identity, 81 
and recording dates were obtained from National Milk Records using ‘Herd Companion’. 82 
Data was taken from Farm 1 between May 2009 and May 2013; Farm 2 between March 83 
2010 and June 2013; and Farm 3 between May 2011 and August 2013. Any data from the 6-84 
week period after a tuberculin testing was excluded. None of the cows in this study have 85 
had a MAP vaccine administered. 86 
Definitions 87 
Paratuberculosis disease status 88 
The date of first seropositive antibody response was defined as Time0. Seropositive as 89 
defined by the laboratory at >30 S/P % using the ELISA antibody test. All recruited 90 
seropositive cows had been seronegative on at least two tests prior to seroconversion. 91 
Dependent on subsequent antibody responses, positive cows were then grouped into 92 
antibody response groups (ARG). The groups consist of: 93 
 High – a seropositive occurs with all subsequent tests are positive (minimum of two). 94 
5 
 
 Progressive – one or more positives occur, followed by one or more negative results, 95 
before another positive occurs with all subsequent tests to this second positive being 96 
positive (minimum of two). 97 
 Transient – one isolated positive occurs with all subsequent tests seronegative 98 
(minimum of two). 99 
Cows that were seropositive but could not be grouped due to missing data were excluded 100 
from the study.  101 
Within each farm, one control cow was matched with each positive cow based on same 102 
parity and calving dates within one month of each other. The control cow would have a 103 
negative antibody result for MAP which corresponded to the first positive antibody result of 104 
the case cow; the same day that these antibody results were recorded was known as 105 
‘Time0’.The matched controls were seronegative throughout the testing period and in case 106 
there were multiple control cows available, one was selected randomly.  107 
Somatic Cell Count 108 
The point that a positive antibody result was first recorded was defined as Time0, and milk 109 
recordings before, at and after Time0 were used to evaluate the occurrence of subclinical 110 
mastitis. As dry periods and missed milk recording may skew the data, milk recordings more 111 
than 100 days apart from Time0 were excluded from the dataset. Due to the range and non-112 
normal distribution of SCC, SCC was converted using the natural logarithm (Ln(SCC)). The 113 
Ln(SCC) values produced a bell-shaped histogram and had non-significant Kolmogorov-114 
Smirnov values; Ln(SCC) values were therefore considered to have a normal distribution. We 115 
reported the summarised SCC levels as continuous SCC (x103cells/ml) by converting the 116 
LnSCC back to SCC. In addition to the continuous data, LnSCC, and as proxy for a (subclinical) 117 
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mastitis event SCCs were categorised into high and low using the cut off value of 118 
200x103cells/ml29.  119 
Statistical Analysis  120 
All data was entered in a spreadsheet using Excel ® (Microsoft Inc.) and all statistical tests 121 
were run using SPSS 25® (IBM Inc.). The Generalised Linear Mixed Model function was used 122 
with Cow ID, nested in Case-Control Pair ID, nested in Farm ID as random effects. This is 123 
done to accommodate for the repeated measurements (Prior, Time0 and Post) and the 124 
Case-Control matching of the regression. The fixed effected were combinations of case vs. 125 
controls and specific ARGs at varying time points, to test an association with the dependent 126 
variables Ln(SCC) and recording of a high cell count event (200x103cells/ml). For the single 127 
time point analysis, paired T-tests (cases vs. controls) were used for the continuous data and 128 
conditional logistic regression for the binary data.  129 
Ethical approval  130 
Informed consent was obtained from each farmer contributing to the study. The Social 131 
Science Research and Ethical Review Board (SSRERB) of the Royal Veterinary College, 132 
University of London has examined and approved the research protocol (SR2017-1378).  133 
 134 
RESULTS 135 
Of the 1590 dairy cows sampled 374 had been seropositive to MAP at some point in the 136 
study period, 262 cows were excluded from further analysis due to not matching the 137 
inclusion criteria. The total number of cows with a positive antibody response (case cows) 138 
included in the study was 112, with 44 classified as high, 15 as progressive, and 53 as 139 
transient. Days in milk and parity were not different, p=0.765 and p=0.931 respectively, 140 
between the positive and negative cows, suggesting the matching on both parameters was 141 
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successful. Other than the somatic cell count reading as reported below, none of the 142 
production parameters was significantly different between the positive cows and their 143 
controls. This included milk yield (kg/day), fat and protein percentage and yields (kg/day). In 144 
addition, no difference in either of these parameters was detected in the ARG subgroups.  145 
Figure 1 shows the individual SCCs of the cows before, at (Time0) and after seroconversion. 146 
The average SCC for all 224 cows within the study at the previous milk recording was 90 147 
x103cells/ml (range: 6 to 3,789 x103cells/ml); at Time0 was 109 x103cells/ml (range: 2 to 148 
4,185 x103cells/ml); and at the subsequent milk recording was 87 x103cells/ml (range: 6 to 149 
4,603 x103cells/ml). In the 112 control cows, the average SCC at the previous milk recording 150 
was 71.9 x103cells/ml, at Time0 was 84.0 x103cells/ml, and at the subsequent milk recording 151 
80.1 x103cells/ml. Whilst in the case cows the median SCC at the previous milk recording 152 
was 111.8x103cells/ml, at Time0 was 140.9 x103cells/ml, and at the subsequent milk 153 
recording was 94.1 x103cells/ml. 154 
The paired t-test showed a significant difference between the Ln(SCC) in case and control 155 
cows at the previous milk recording (p=0.003) and at Time0 (p<0.001). There was no 156 
significant difference found at the subsequent milk recording (p=0.293). SCC as a continuous 157 
variable was then analysed within each ARG; distributions are shown in Table 1. The 158 
statistical analysis showed that there was a significant difference between Ln(SCC) in case 159 
and control cows at the previous milk recording and at Time0 for the High ARG (p=0.010, 160 
p=0.002 respectively), but not for the subsequent recording (p=0.058).  161 
Over time, the SCC values from before, at Time0, and after were not significantly different 162 
for case cows (p=0.058) nor for control cows (p=0.619). Only for the control cows to the 163 
transient ARG showed a significantly different Ln(SCC) over time (p=0.029), none of the 164 
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other ARG or their matched controlled showed significantly different Ln(SCC) levels over 165 
time.  166 
At the 200 x103cells/ml threshold, 28.6% (64/224) of the studied cows had a high SCC at the 167 
previous milk recording, 33.0% (74/224) of them had high SCC at Time0 and 24.6% (55/224) 168 
of them had high SCC at the subsequent milk recording. At the milk recording previous to 169 
Time0, 36. 6% (41/112) showed high SCC in case cows compared to 20.5% (23/112) of 170 
control cows (Adjusted OR = 2.3 (95% CI: 1.2-4.2), p=0.009). High SCC were recorded 41.1% 171 
(46/112) of case cows at Time0 compared to 25.0% (28/112) of control cows (Adjusted OR = 172 
2.0 (95% CI: 1.1-3.5), p=0.026), and 26.8% (30/112) of case cows had a high SCC at the 173 
subsequent milk recording compared to 22.3% (25/112) of control cows (Adjusted OR = 1.3 174 
(95% CI: 0.7-2.4), p=0.450). There was no significant difference over time on the occurrence 175 
of high SCCs differed in case cows (p=0.061) and control cows (p=0.657). 176 
Table 2 shows the occurrence of high SCC in each ARG; cows in the High ARG had more 177 
frequent high SCC at the previous milk recording (OR = 4.7 (95% CI: 1.5-14.7), p=0.008), at 178 
Time0 (OR = 7.8 (95% CI: 2.1-29.8), p=0.003) and subsequent recording (OR = 3.3 (95% CI: 179 
1.1-10.3), p=0.037), based on the conditional logistic regression. In the Transient ARG, the 180 
frequency of high SCC recordings at the different time points was different in case (p=0.014) 181 
as well as control cows (p=0.034), but there was no significant difference observed over 182 
time in the other ARGs. 183 
 184 
DISCUSSION 185 
The results show that cases cows tended to have increased SCCs around the time that 186 
seroconversion occurred compared to matched control cows; both at the point the antibody 187 
test first became seropositive (Time0) as well as the milk recording approximately one 188 
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month earlier. In particular, this was the case in cows that had a consistently high antibody 189 
response (High ARG). SCCs for case and control cows at the subsequent milk recording were 190 
not significantly different. Cows that showed a progressively positive antibody response 191 
(Progressive ARG) did not show a consistent pattern, which is maybe due to the limited 192 
sample size (15 case cows).  193 
The results suggest that cows that are progressing to MAP seropositive status have 194 
concurrent elevated SCC as well as during the time period leading up to this point, 195 
compared to matched control cows. A longitudinal study identified that a cow’s age at the 196 
point it had its first high SCC was positively associated with its age when it had its first 197 
positive antibody titre to MAP26. This study however did not identify the sequence of 198 
events, where we identified the occurrence of high SCC to precede the seroconversion. Part 199 
of the complexity is the poor sensitivity of the serological test for Johne’s disease, which 200 
increases by repeated testing and also with age30. This could be explained via different 201 
pathways; one explanation would be the presence of a confounding, underlying, and yet 202 
unknown factor that predisposes cows to have a high SCC and to go through 203 
paratuberculosis disease progression. Glucocorticoids are believed to influence 204 
differentiated T-helper cells to alter their cytokine repertoire from a Th-1 to a Th-2 205 
pattern31. Therefore, if the cow was put under significant stress and cortisol was released 206 
into the circulation, the bovine immune response might become Th-2 dominated with both 207 
conditions being affected similarly. A similar response is also seen around the time of 208 
parturition and is believed to be one of the factors that contributes to increased incidence 209 
of severe clinical mastitis during this period32,33,34 as well as milk seropositive 210 
paratuberculosis cases post-partum35.  211 
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Another pathway to consider is that cows that have an escalating MAP infection predisposes 212 
them to having a high SCC, a compromised immune system due to a MAP infection might 213 
make the host’s immune system susceptible to mastitis. Dotta and others showed that 214 
subclinical paratuberculosis resulted in the reduction of migratory responses of 215 
polymorphonuclear cells of the bovine immune system in vitro36. It has also been well 216 
documented that the innate immune response is vital for cows to undergo spontaneous 217 
cures and therefore a disease that prevents a rapid milk neutrophil response might 218 
predispose cows to developing mastitis 34,37. A review by Burton and Erskine (2003) 219 
concluded the Th-1 immune response can be particularly beneficial against mastitis with the 220 
immunoglobulin isotype IgG2 having a major role in this preferential cell mediated immune 221 
response34. IgG2 secretion by B-cells is enhanced by interferon-γ and is the main opsonin 222 
supporting neutrophil phagocytosis in milk34,38. If MAP infected macrophages are able to 223 
subvert host immune responses to a Th-2 immune response as described above, the 224 
question is whether MAP infection could negatively affect the host’s ability to fight new 225 
mastitis infections. Further research is needed to identify whether the lowered local 226 
immune response (udder and intestine) are two separate events, or centrally linked.  227 
The observation that the number of case cows that had a high SCC prior to (36.6%) and at 228 
Time0 (41.1%), compared to after (29.5%) supports the notion of the third explanation: 229 
having subclinical mastitis may accelerate cows’ paratuberculosis disease progression. 230 
Although mastitis infections are known to cause significant increases in cytokines that 231 
promote a Th-2 immune response, these are generally produced alongside large quantities 232 
of pro-inflammatory cytokines and interferon –γ which are central to the innate immune 233 
response – the primary host determinant for dictating the outcome of the mastitis 234 
infection34,39,40. In some cases of mastitis, somatic cell counts can increase to over 235 
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1,000x103cells/ml and with a milk yield of 25 litre per day, this is nearing 10% of the cows 236 
granulocyte daily turnover, putting pressure on the cow’s immune system and potentially 237 
hindering its attempts to control a MAP infection41.  238 
Limitations to the study are the frequency of testing (SCC and milk ELISA), the limited 239 
sensitivity of the test available and the lack of a measure of a central versus a local immune 240 
response. Also, the study design does not allow us to be conclusive on what explanation is 241 
best, the current data suggests that cows infected with MAP that were becoming 242 
seropositive to the condition for the first time have increased somatic cell counts around 243 
the same time. This association was evident at the first seropositive test, as well as at the 244 
milk recording before, approximately a month earlier. This highlights a possible relationship 245 
between the two conditions occurring. Further work involving more frequent testing is 246 
required to determine a more precise temporal relationship than this study could achieve 247 
with a comparison on quarterly testing for MAP and monthly testing of SCC. It remains 248 
uncertain when cows will seroconvert, leaving a practical study design challenging to 249 
execute. While treatments for mastitis were not included in this study, this could be 250 
included to ensure the similar SCC in all groups at milk recordings subsequent to Time0 was 251 
not a treatment effect. 252 
Further work could look at the use of raised SCC as a potential means of selecting cows for 253 
additional MAP testing. While the sensitivity, specificity, accuracy and positive predictive 254 
value of raised SCC for predicting MAP seroconversion is probably insufficient diagnostically, 255 
it may aid in the surveillance in some herds. A prospective cohort study with more frequent 256 
(weekly) SCC and Johne’s milk ELISA testing will allow us to evaluate these dynamics better. 257 
In such proposed work, it would be advisory to evaluate the Th1/Th2 preference of the 258 
12 
 
peripheral blood monocytes to evaluate whether the two local immune responses in the 259 
intestine and the udder are linked centrally, or not. 260 
To conclude, this study found cows infected with MAP have increased SCC close to the time 261 
that they first became seropositive. This is identified for the periods before and at the point 262 
seroconversion was first diagnosed, suggesting that an increased SCC might be predisposing 263 
cows towards this progression of MAP. Due to the nature of the paratuberculosis and the 264 
study design used, a possible causative pathway cannot be supported; a temporal 265 
relationship, however, can be suggested. 266 
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Table 1: Average somatic cell count (x103cells/ml) in case and control cows by antibody 412 
response group, number of cows presented in brackets. Time0: recording when the first 413 
positive antibody result occurred. *: different case vs. control p<0.05. #: different SCC 414 
level over the reported time period p<0.05. 415 
 
Average somatic cell count 
(x103cells/ml) 
Antibody Response Group 
High (44) Progressive (15) Transient (53) 
Control Case Control Case Control# Case 
Previous recording 54 105* 146 142 75 110* 
Time0 57 127* 93 126 112 159 
Subsequent recording 64 102 77 100 98 86 
 416 
  417 
20 
 
Table 2: High somatic cell count prevalence in case and control cows by antibody response 418 
group, number of cows presented in brackets. Time0: recording when the first positive 419 
antibody result occurred. *: different case vs. control p<0.05. #: different number of high 420 
SCC events over the reported time period p<0.05. 421 
Percentage of high 
SCC 
(>200x103cells/ml) 
Antibody Response Group 
High (44) Progressive (15) Transient (53) 
Control Case Control Case Control# Case# 
Previous recording 11.4% 36.4%* 46.7% 33.3% 20.8% 37.7% 
Time0 6.8% 36.4%* 26.7% 33.3% 39.6% 47.2% 
Subsequent recording 13.6% 31.8%* 33.3% 33.3% 20.8% 26.4% 
 422 
 423 
